TL;DR
Get kitchen staples and gadgets delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A Food Safety News publisher says he and co-petitioners are seeking action through seven petitions to the FDA and USDA’s Food Safety and Inspection Service. The proposals address infant formula testing, food warnings, poultry rules, outbreak investigations and disclosure of firms implicated in outbreaks; the supplied report does not establish that agencies have acted on them.
A Food Safety News publisher says he and a group of co-petitioners are pressing the FDA and USDA’s Food Safety and Inspection Service to change how federal agencies test foods, warn consumers and investigate outbreaks. The seven petitions address products and practices linked in the report to illness outbreaks, but the supplied material does not confirm that the agencies have accepted or acted on the requests.
The publisher describes petitions seeking finished-product testing for botulinum neurotoxin-producing clostridia in powdered infant formula, along with testing of dairy-based ingredients used to make it. He says existing federal rules require formula manufacturers to test finished products for Cronobacter and Salmonella. The petition is being brought with 46 parents of 24 infants, according to the report. The publisher cites 52 infant hospitalizations with botulism in the ByHeart and Nara Organics outbreaks since 2023, and says the organism was found in a dairy ingredient.
Two FDA petitions would add consumer warnings to packaging. One seeks a prescribed warning for cheese made from unpasteurized milk, a completed review of the federal 60-day aging rule, and validation that aging used by cheesemakers works. The other seeks warnings on packaged raw and lightly cooked sprouts, including sprouts in salads, sandwiches and wraps. The publisher says FDA has advised certain higher-risk groups against eating raw sprouts for 28 years, but has not put that advice on product packaging.
The requests to FSIS concern Salmonella in raw poultry. The publisher asks the agency to classify Salmonella at or above 1 CFU per gram as an adulterant in raw ground chicken and turkey and raw chicken parts, or alternatively to apply the determination to three serotypes: Infantis, Enteritidis and Typhimurium. At minimum, he asks FSIS to begin verification sampling. Other petitions ask FDA for limited, outbreak-triggered access to animal feeding operations to collect samples, and for a written standard to disclose firms implicated by evidence in outbreaks.
How the Petitions Could Change Safeguards
The proposals span several points in the food-safety system: preventing contaminated products from reaching consumers, helping people identify risks before eating, and collecting information during outbreaks. If adopted, the requested testing and poultry standards could affect what manufacturers and producers must check or keep out of commerce. Warning labels could give consumers information at the point of purchase that the publisher says agencies already provide through other channels.
The petitions also raise questions about the balance between outbreak investigation and business confidentiality. The publisher argues that consumers should be told which firms are implicated when epidemiological and traceback or laboratory evidence supports that link. Identifying a firm before an investigation is complete can carry consequences, so any agency standard would need to explain what evidence triggers disclosure and how uncertainty is communicated. The petitions are requests for government action, not proof that the requested policies have been adopted or that every cited outbreak has a confirmed source.
As an affiliate, we earn on qualifying purchases.
Earlier Rules and Outbreak Decisions
The report points to existing rules and agency actions as the basis for several requests. For infant formula, it says federal finished-product testing requirements currently name Cronobacter and Salmonella, not the botulinum neurotoxin-producing clostridia sought in the petition. For raw-milk cheese, it challenges a 60-day aging rule dating to the 1940s. The publisher says FDA announced a reevaluation in 2013, while the petition asks the agency to complete that review and require validation when aging is used as a safety measure.
For poultry, the publisher cites a May 2024 FSIS determination that Salmonella at or above 1 CFU per gram is an adulterant in breaded stuffed raw chicken products. He says the agency planned a later rulemaking for other raw poultry, withdrew that proceeding in April 2025, and postponed verification sampling indefinitely in December 2025. On outbreak access, the report contrasts FDA’s 1975 rule concerning Salmonella in pet turtles with its investigation of the 2018 Yuma romaine outbreak, when the agency reportedly found the outbreak strain in an irrigation canal beside a large cattle feedlot and collected six samples inside the operation.
The disclosure request follows examples the publisher says show differing levels of public detail. He cites an FDA announcement on September 10, 2026, about a 14-person E. coli O157:H7 investigation that identified romaine but did not name a grower, processor, brand or state; an earlier 89-person romaine outbreak; and a separate outbreak linked by agencies to ready-to-eat multi-ingredient chicken wraps. The report says the brand in the latter case became public through a lawsuit. These are the publisher’s account of the investigations and disclosure history.
food allergy warning labels for cheese
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Filing Status and Agency Responses
The supplied report describes the petitions and their requested remedies, but does not establish the filing date or receipt status of every petition, whether FDA or FSIS has opened formal proceedings, or how either agency will respond. The source text ends during its description of the disclosure petition, so the full requested language and any remaining petition details are not available here.
The report also does not provide agency responses to the publisher’s account of past outbreak investigations, the cited illness figures, or the interpretation of existing rules. It remains unclear whether regulators agree with the petitions’ scientific and legal arguments, what evidence they would require before changing testing or labeling policies, and whether any proposed changes would face public comment or litigation.
As an affiliate, we earn on qualifying purchases.
Agency Review and Petition Outcomes
The next concrete development would be confirmation that each petition has been filed and accepted for review, followed by responses from FDA and FSIS. The agencies could grant a request, deny it, seek additional information or address the issues through rulemaking or other policy actions. No decision timetable is provided in the supplied report.
Readers should watch for agency notices, written responses and any proposed rules that specify testing thresholds, warning language, sampling authority or disclosure standards. Until those steps are documented, the seven petitions represent requests for changes, not changes to current federal requirements.
As an affiliate, we earn on qualifying purchases.
Key Questions
What are the seven petitions asking federal agencies to do?
They seek changes involving infant-formula testing, raw-milk cheese and sprout warnings, Salmonella rules and sampling for raw poultry, FDA access to animal feeding operations during certain outbreaks, and disclosure of firms implicated in outbreaks. The supplied report’s account of the final petition is incomplete.
Have FDA or FSIS adopted these proposals?
The source describes requests made to the agencies but does not confirm that either agency has adopted them or issued a response.
Who is backing the infant-formula petition?
The publisher says the petition is being filed with 46 parents of 24 infants affected in the cited ByHeart and Nara Organics botulism outbreaks.
What would the proposed outbreak access authority allow?
As described by the publisher, it would let FDA enter an animal feeding operation and collect environmental and animal samples when the agency has determined in writing that the operation is implicated in a multistate outbreak. The request excludes seizures, husbandry rules and access to financial records.
When could the agencies decide?
The report gives no decision dates or review schedule. The timing and outcome depend on FDA and FSIS responses and any rulemaking or other process that follows.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
